Previous Article | Next Article ![]()
Infection and Immunity, October 1998, p. 4856-4866, Vol. 66, No. 10
Division of Infectious Diseases,
Received 5 March 1998/Returned for modification 22 June
1998/Accepted 22 July 1998
Experimental Helicobacter pylori infection was studied
in Mongolian gerbils with fresh human isolates that carry or do not carry cagA (cagA-positive or
cagA-negative, respectively), multiply passaged laboratory
strains, wild-type strain G1.1, or isogenic ureA,
cagA, or vacA mutants of G1.1. Animals were
sacrificed 1 to 32 weeks after challenge, the stomach was removed from
each animal for quantitative culture, urease test, and histologic
testing, and blood was collected for antibody determinations. No
colonization occurred after Helicobacter pylori is an
important bacterial pathogen that causes chronic gastritis and is
associated with gastroduodenal ulcer disease, adenocarcinoma of the
distal stomach, and gastric lymphoma in humans (13). Animals
used for studying experimental H. pylori infection
(19) include monkeys, dogs, piglets, domestic cats, and
rodents (14, 15, 21, 31, 32, 35, 37, 46, 47). Several models
described thus far are not optimal, since the animals cannot be handled
with ease or in large numbers, germ-free conditions must be used, or
infection rates are rather low. Excellent models involving
Helicobacter species other than H. pylori exist (4, 20, 38), but their applicability to H. pylori
infection is limited by the differences between the organisms.
Infection of conventional mice with H. pylori overcomes many
of these problems (40), although infection is either not
easily achieved and/or is transient (31, 40). In general,
the gastritis induced appears less intense than in humans (29, 40,
42, 54) or is restricted to the use of highly selected
mouse-adapted strains (39), limiting the utility of these
models for examining H. pylori isolates from humans.
Published results about experimental H. pylori infection in
Mongolian gerbils appear promising, although somewhat conflicting. Gastritis was minimal in the initial report by Yokota et al.
(59) but quite pronounced in later studies (29,
41) that used similar experimental conditions, including the same
cagA-positive H. pylori strain (ATCC 43504)
(29) and the same source of gerbils (29, 41). The
authors (29) therefore raised the question whether the
differences in histopathology could be due to the inbred gerbil strain
(MGS/Sea; Seiwa Experimental Animals, Fukuoka, Japan) they used. The
histomorphology of the gerbil stomach corresponds closely to that of
the mouse and rat stomach (24). Naturally acquired gastritis
among gerbils is rare, occurring in only 3 (2%) of 141 animals
examined, in each case as a necrotizing form (6). Moreover, natural infection of gerbils with Helicobacter species does
not appear to occur (5, 57). These points suggest that
Mongolian gerbils are suitable to study experimental H. pylori infection. Our goals were to evaluate whether infection
with wild-type and mutant H. pylori strains in Mongolian
gerbils induces gastritis and to define parameters important for
gastric colonization and inflammation.
Animals and housing.
Outbred Mongolian gerbils
(Meriones unguiculatus) with a body weight of 30 to 50 g, corresponding to an age of approximately 4 to 8 weeks (9,
26), were purchased from Harlan Sprague-Dawley, Inc.
(Indianapolis, Ind.) (Hsd:MON) or Charles River Laboratories (Wilmington, Mass.) [Crl:(MON)BR (outbred)]. Up to six animals per
solid-bottom cage were housed in the Animal Care Facilities of
Vanderbilt University in a room with a 12-h light-dark cycle at 21 to
22°C and fed a standard commercial rodent chow. Access to food and
water was free throughout all experiments. No special pretreatments
(such as acid inhibition or antibiotics) were used before orogastric
H. pylori inoculation or before the animals were sacrificed.
Since only a few experiments were carried out with female gerbils, all
other experiments were done with male gerbils when not otherwise
indicated. All experiments and procedures carried out on the animals
had been approved by the institutional Animal Care Committee of
Vanderbilt University (protocol M/95/291).
H. pylori wild-type and mutant strains used for
inoculation.
Fresh human cagA-positive (B127, B128, and
B129) or cagA-negative (SW18, B102, B108, and B120) H. pylori isolates were obtained from patients with duodenal ulcers
(strains B127, B129, and SW18) or gastritis alone (strains B128, B102,
B108, and B120) who were undergoing gastrointestinal endoscopy at the
Nashville Department of Veterans Affairs Medical Center or the
Gastroenterology Division, University Hospital, Zurich, Switzerland.
The isolates were grown on Trypticase soy agar plates with 5% sheep
blood (BBL Microbiology Systems, Cockeysville, Md.) for 3 to 5 days
under microaerobic conditions and characterized as H. pylori, as previously described (56). The
cagA status was determined by PCR with chromosomal DNA, as
previously described (55). Aliquots of the human H. pylori isolates with fewer than five in vitro passages were
frozen, and stock cultures were maintained at H. pylori inoculation and animal sacrifice.
H.
pylori strains for each challenge were started from freezer stocks
and were grown on Trypticase soy agar plates with 5% sheep blood.
After 24 to 36 h, the cells were harvested in brucella broth
(BBL), the concentration was adjusted according to the OD at 550 nm,
and the cells were administered to the animals immediately after
harvest. The animals were orogastrically inoculated three times (days
0, 2, and 4) with 0.8 to 1.0 ml of an H. pylori cell suspension of 109 to 1010 CFU/ml in sterile
brucella broth through a feeding needle. Age- and sex-matched control
animals were inoculated with identical volumes of sterile brucella
broth alone. Alternatively, in one experiment, H. pylori
G1.1+0 and G1.1+35 were grown for 24 h in brucella broth
supplemented with 5% fetal calf serum for subsequent challenge of
109 CFU in 0.8 to 1.0 ml.
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Experimental Infection of Mongolian Gerbils with
Wild-Type and Mutant Helicobacter pylori Strains
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
20 in vitro passages of wild-type strain
G1.1 or with the ureA mutant of G1.1. In contrast,
infection occurred in animals challenged with wild-type G1.1 (99 of 101 animals) or the cagA (25 of 25) or vacA (25 of
29) mutant of G1.1. Infection with G1.1 persisted for at least 8 months. All 15 animals challenged with any of three fresh human
cagA-positive isolates became infected, in contrast to only
6 (23%) of 26 animals challenged with one of four fresh human
cagA-negative isolates (P < 0.001).
Similar to infection in humans, H. pylori colonization of
gerbils induced gastric inflammation and a systemic antibody response
to H. pylori antigens. These data confirm the utility of
gerbils as an animal model of H. pylori infection and
indicate the importance of bacterial strain characteristics for
successful infection.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
70°C in brucella
broth (BBL) supplemented with 15% glycerol. ICR mouse-passaged
cagA-positive strain CPY3401 (31), originally
isolated from a duodenal ulcer patient, was kindly provided by Satoru
Matsumoto and Mikio Karita; after gerbil passages and expansion of a
single colony, it was designated G1.1WT (wild type).
cagA-positive H. pylori strains J223, HPK127,
CPY3401, 26695, and HPK5 are from the Nashville strain collection and
have been described previously (55); all these strains had
been passaged in vitro multiple times without documentation of the
exact number of passages. Therefore, immediately after isolation from
the gerbil stomach, strain G1.1 was passaged on blood plates 70 times
and aliquots were frozen every 5 passages, yielding strains G1.1+0 to
G1.1+70. Lewisx and Lewisy expression of
strains before and after passage was determined by enzyme-linked
immunosorbent assay (ELISA) with monoclonal antibodies, as previously
described (55). Chromosomal DNA was extracted from each of
the preserved strains between G1.1+0 and G1.1+70 for genotypic
comparison by random amplified polymorphic DNA PCR (RAPD-PCR; see
below). The frequencies of natural transformation for strains G1.1+0
and G1.1+35 were compared by using chromosomal DNA from G1.1
ureA (see below). Chromosomal DNA from G1.1+0 and G1.1+35
was used for natural transformation (approximately 20 ng of
DNA/109 cells) of cells of strains G1.1+0 and G1.1+35.
Equal numbers of bacterial cells, based on the optical density (OD) at
550 nm, were then inoculated into gerbils to examine for selection of transformants able to colonize in vivo.
) or ureA
(G1.1U
) mutants were obtained by natural transformation
with chromosomal DNA from the respective CPY3401 mutants in which
cagA or ureA had been interrupted by insertion of
a cassette of xylE and a kanamycin resistance
(aphA) gene (33). G1.1 vacA
(G1.1V
) was obtained by natural transformation of G1.1
with pV2.2(xylE/aphA), which was created by blunt-end
ligation of the 2.6-kb KpnI-SacI fragment from
pMK1 containing the xylE/aphA cassette (33) into the unique BglII site (nucleotide [nt] 2950) of a
PCR-amplified 2.4-kb vacA fragment cloned into pT7Blue
(Novagen, Madison, Wis.) with selection for resistance to kanamycin (30 µg/ml). The vacA PCR fragment (nt 1708 to 4134) was
obtained with the primers 5'-TAGTAACAAGACTCATAT (nt 1708 to
1725) and 5'-AAGCTTGATTGATCACTCC (nt 4134 to 4116; primer 6 [12]) for 35 amplification cycles of 94°C for 1 min, 41°C for 2 min, and 72°C for 2 min. Mutants were characterized by
kanamycin resistance and by XylE activity by using a 10 mM catechol
solution in water, and the site of insertion in all mutants was
confirmed by PCR with cagA, ureA, or
vacA primers flanking the insertion site together with an
outward-pointing xylE and aphA primer,
respectively (33); G1.1WT served as a control.
Isolation and characterization of H. pylori from gerbils. Each stomach specimen in a standardized total volume of 2 ml of PBS was homogenized, and 100-µl aliquots of undiluted and 10-fold-diluted homogenate (corresponding to 1/40 and 1/400 of the entire stomach, respectively) were plated on selective Trypticase soy agar-5% sheep blood plates containing vancomycin (20 µg/ml), nalidixic acid (10 µg/ml), bacitracin (30 µg/ml), and amphotericin B (2 µg/ml) (Sigma Chemical Co., St. Louis, Mo.) and grown for 3 to 5 days, as previously described (55). The colonies were counted after 4 and 5 days, and the results are expressed as CFU/stomach. In each case, colonies were identified as H. pylori based on their resistance to the above antibiotics, characteristic morphology on plates, and urease and oxidase activity of multiple colonies collected with a swab from the primary-culture plate. RUT was performed by incubating 100 µl of undiluted homogenate with 100 µl of filter-sterilized 0.05% phenol red-2% urea in 0.01 M sodium phosphate (pH 6.5) (27) at room temperature and was evaluated after 12 h. As controls, gastric homogenates of brucella broth-challenged animals were regularly included. Oxidase activity was tested by using the DrySlide oxidase test (Difco Laboratories, Detroit, Mich.). G1.1 mutant strains were additionally tested for kanamycin resistance and XylE activity, as described above. Chromosomal DNA extracted from the H. pylori challenge strain G1.1 and from isolates obtained after 1, 4, 8, 12, 16, and 24 weeks of colonization was examined by RAPD-PCR with 10-nt primers 1281, 1254, and 1247 (2).
Histopathologic testing. Formalin-fixed tissue samples were processed routinely and stained with hematoxylin and eosin. For better visualization of H. pylori in the tissue sections, silver staining was performed. Briefly, after the deparaffinized tissue sections were sensitized for 5 min with 1% (wt/vol) uranyl nitrate in H2O and rinsed in distilled H2O, staining was performed by covering the sections for 1 h at room temperature with a freshly mixed solution consisting of 2 volumes of 50% (wt/vol) silver nitrate in H2O and 1 volume of 1% formic acid with 2% (wt/vol) gelatin (49). Histologic evaluation was done by a single pathologist (K.T.T.) blinded to the experimental data. As semiquantitative estimates, the following parameters each were graded from 0 to 3 in the gastric antrum, body, and duodenum: acute inflammation, chronic inflammation, and spiral organisms in the gastric glands. One or no foci of inflammation per low-power field with a 10× objective was graded as 1, more than one focus but less than half of the mucosa was graded as 2, and diffuse or multifocal inflammatory infiltration of more than half the mucosa was graded as grade 3. Few single organisms or no more than two small clusters of silver-stainable organisms in the gastric glandular lumina per high-power field with a 40× objective was grade 1; three to six clusters was grade 2; and more than six clusters was grade 3. Because of the paucity of spiral silver-stainable organisms on the mucosal surface, bacteria in this location were graded from 0 to 2, where grade 0 represented no detectable organisms; grade 1 represented a few single organisms; and grade 2 represented a few small clusters of organisms. Lymphoid aggregates were graded as present or absent. In parallel with mucosal (superficial) inflammation, inflammation also was graded from 1 to 3 for density of the cellular infiltrates within the gastric wall on the serosal aspect of the muscularis mucosae and was referred to as deep inflammation. For each animal, the grading for each region was based on evaluating all tissue available for this region on one microscopic slide. The total diameters of the specimens of the duodenum, antrum, and body were 3.6 ± 2.8, 14.8 ± 6.6, and 18.0 ± 6.8 mm, respectively.
Serum antibodies to H. pylori.
For evaluation of the
time course of the systemic immune response to H. pylori, a
group of gerbils were tail bled before and 2, 3, 4, 5, 6, 8, and 12 weeks after orogastric challenge and at sacrifice. Serum samples were
stored at
20°C before being used for antibody determinations.
Immunoglobulin G (IgG) or IgM antibody levels in serum were measured by
ELISAs. Immulon 2 flat-bottom microtiter plates (Dynatech Laboratories,
Inc., Chantilly, Va.) were coated with 100 µl of a whole-cell
sonicate of H. pylori G1.1, corresponding to 1 µg of
protein per well as determined by the bicinchoninic acid protein assay
(Pierce, Rockford, Ill.). Sera were diluted 1:500 or 1:100 in PBS-1%
bovine serum albumin for determination of IgG or IgM, respectively.
Specific detection of gerbil Ig by goat anti-mouse Ig (25),
gerbil IgG by sheep or goat anti-mouse (48, 53, 61) or goat
anti-hamster (1) IgG, and gerbil IgA by goat anti-mouse IgA
(61) has been described previously. Therefore, bound gerbil
IgG antibodies were detected by goat anti-mouse IgG and, by analogy,
gerbil IgM was detected by goat anti-mouse IgM antibodies coupled with
alkaline phosphatase (Sigma) and p-nitrophenylphosphate as
the substrate, using methods described previously (55). The
results were expressed as OD units (1 OD unit = 1,000 OD410) corrected for the OD values obtained from controls
without conjugate. Serum samples from animals before challenge with
H. pylori and after challenge with brucella broth served as
negative controls and selected positive sera served as positive
controls in subsequent assays. The OD variation of the controls between
different assays was within a range of ±10%.
Statistical analysis. Bacterial CFU and OD units were expressed as mean ± standard error of the mean (SEM). Proportions were compared by using Fisher's exact test. ODs and CF units were compared by using Student's t test for a comparison of means of independent samples or one-way analysis of variance. In two-tailed analyses, P < 0.05 was considered significant.
| |
RESULTS |
|---|
|
|
|---|
Inoculation of H. pylori G1.1WT and mutant strains. To assess its ability to colonize the gerbil stomach, the mouse-passaged strain CPY3401 was first passaged through gerbils. In contrast to the multiply in vitro-passaged CPY3401, gerbils could be colonized with this strain recovered from freezer stock, and the gerbil-passaged, reisolated, and clonally expanded strain then was called G1.1 for further use.
Having available a strain that reproducibly colonizes the gerbil stomach, we then created isogenic U
, C
, and
V
mutants of G1.1 to examine the effect of ablation of
ureA, cagA, and vacA, respectively, in
G1.1 on gastric colonization and inflammation in Mongolian gerbils. The
results of experimental infection of gerbils with G1.1WT and mutant
strains are summarized in Table 1.
Compared with the colonization rate of 98% with G1.1WT, ablation of
ureA (G1.1U
) completely abolished colonization
whereas ablation of vacA (G1.1V
) only slightly
reduced the colonization rate (to 86%) (P = 0.024, Fisher's exact test) and ablation of cagA
(G1.1C
) had no effect at all (100%). There was no
evidence for spontaneous clearance of the infections for up to 32 weeks
for animals infected with G1.1WT or for up to 12 weeks (maximum
observation period) for animals infected with the G1.1C
or G1.1V
mutant. In parallel to the ratios of
infected-to-challenged animals, the mean levels of colonization
determined by quantitative culture remained stable between
104 and 105 CFU/stomach for both G1.1WT and the
G1.1C
or G1.1V
mutants during the
observation periods (Fig. 1). Analysis by RAPD-PCR of G1.1 isolates recovered after 1, 4, 8, 12, 16, and 24 weeks
of infection showed virtually identical patterns to those of the
inoculation strain G1.1.
|
|
Effect of the number of challenges on colonization. To examine whether the number of challenges necessary to induce infection could be reduced, we compared the ratios of infected-to-challenged gerbils after one, two, or three orogastric inoculations with H. pylori G1.1. Whereas in one experiment all four animals in each group challenged one to three times (n = 12) were infected 12 weeks after challenge (a total of 12 animals), in another experiment in which five gerbils per group were challenged once with 1 × 108, 5 × 108, 1 × 109, or 5 × 109 CFU of G1.1, based on measurement of the OD550, only two or three animals were infected 2 weeks after challenge with the three higher doses and one animal was infected after challenge with the lowest dose, as detected by culture (a total of 8 of 20 animals). Based on these findings, we concluded that in our hands, experimental infection of Mongolian gerbils with H. pylori in a single-challenge protocol would provide results that were too unpredictable. Therefore, in all future experiments, we used three challenges.
Inoculation of fresh human H. pylori isolates. After establishing colonization of gerbils with an H. pylori strain (G1.1) that had been both mouse and gerbil passaged and with mutants derived from this strain, and after finding no colonization with a multiply in vitro-passaged version of the same strain (see below), we examined whether gerbils could be infected with fresh clinical cagA-positive or cagA-negative isolates of human origin. All 15 gerbils challenged with one of three fresh human cagA-positive H. pylori isolates (B127, B128, and B129) became infected. Only 6 (23%) of 26 gerbils challenged with one of four fresh cagA-negative isolates (B108 [2 of 5], SW18 [2 of 5], B120 [2 of 6], B102 [0 of 10]) became infected, a significant (P < 0.001, Fisher's exact test) difference from the results of challenges with fresh human cagA-positive H. pylori isolates.
Infection of gerbils with cagA-positive H. pylori B127, B128, or B129 has been documented for up to 8 weeks thus far. Parallel to G1.1WT and the G1.1V
mutant, comparison of
colonization levels at up to 6 weeks and after 6 weeks of infection for
H. pylori B127, B128, and B129 did not show a significant
tendency of the mean CFU/stomach to decrease with time (data not
shown), but long-term experiments with these strains are required.
Next, we determined whether other in vitro-passaged strains were able
to colonize gerbils or whether this phenomenon was specific for G1.1.
Effect of in vitro passaging of G1.1 on colonization.
Since
for several of the strains used in our animal studies, the exact number
of in vitro passages after isolation from human gastric biopsy
specimens was not documented, we studied the effect of sequential in
vitro passaging of strain G1.1 on its ability to colonize the gerbil
stomach. Comparison of gerbils infected with strain G1.1 that was
freshly isolated from the gerbil stomach with those infected with
strains obtained after an additional 10 to 35 in vitro passages on
blood plates showed a progressive diminution of colonization ability,
until after 20 passages, colonization was lost. The ratio of infected
to challenged animals decreased from 10 of 10 animals challenged with
G1.1+0 to 7 of 10 challenged with G1.1+10, 1 of 5 challenged with
G1.1+15 (P = 0.004), and 0 of 20 challenged with
G1.1+
20 (P < 0.0001), resulting in a continuous
decrease of the average CFU per challenged animal with increasing in
vitro passage (Fig. 2). In contrast to
the results obtained with the freshly isolated human strains, none of
five animals challenged in each group with one of five multiply in vitro- passaged human cagA-positive H. pylori
strains (J223, HPK5, HPK127, CPY3401, and 26695) became colonized.
|
Attempts to reverse the effect of in vitro passaging on
colonization ability.
Having defined for G1.1 the exact number of
in vitro passages that abolishes its ability to colonize the gerbil
stomach, we tested whether this in vitro-induced inability to colonize
could easily be overcome. First, rechallenge with the G1.1+15 isolate that was recovered from the one infected animal induced colonization in
three of five animals (mean log10 of 4.08 CFU/stomach), in contrast to one of five animals infected with the original G1.1+15 strain (log10 of 3.71 CFU [not significant]). Second, to
determine whether the in vitro-induced changes were due to the growth
of H. pylori on solid medium, gerbils were challenged three
times with G1.1+35 grown in brucella broth supplemented with 5% fetal bovine serum. However, none of five animals was found to be infected by
2 weeks after challenge, whereas all five control animals inoculated with broth-grown G1.1+0 were infected. Third, since H. pylori G1.1 is naturally competent for transformation in vitro by
chromosomal DNA from itself with an approximate frequency of
10
6 to 10
7 for the occurrence of
G1.1U
and 10
8 to 10
9 for
G1.1A
or G1.1V
, we examined whether the
ability to colonize could be transferred from the colonizing strain
(G1.1+0) to the multiply in vitro-passaged strain (G1.1+35) by
transforming growing G1.1+35 cells with chromosomal DNA from G1.1+0. In
contrast to direct selection in vitro for a marker in a conventional
natural transformation experiment, the G1.1+35 recipients were cultured
to expand the population and then 1010 CFU was inoculated
three times at 2-day intervals into gerbils to potentially select for
colonizing transformants in vivo. Inocula of G1.1+0 transformed with
chromosomal DNA extracted from G1.1+0 or G1.1+35 and inocula of G1.1+35
transformed with DNA from G1.1+35 were used as controls. In an
additional control experiment, G1.1U
transformants were
found for G1.1+0 and G1.1+35 at a similar frequency of
10
6 to 10
7, indicating that the natural
competence of H. pylori G1.1 remained unchanged during
extended in vitro passage for more than 1 month. Cells of G1.1+0 or
G1.1+35 were equally urease positive in the RUT. Similarly, cells of
G1.1 after 0 to 70 in vitro passages were indistinguishable in
Lewisx and Lewisy expression and in RAPD-PCR
with chromosomal DNA (results not shown). None of five animals in each
group became infected with strain G1.1+35 transformed with DNA from
either G1.1+0 or G1.1+35, whereas all five animals in each group
challenged with G1.1+0 transformed with DNA from G1.1+0 or G1.1+35
became infected. Similarly, none of the G1.1+35 isolates after passage
through different mouse strains (BALB/cBy, C57BL/10, and C3H/HeJ) and
freshly recovered from the mouse stomach was able to colonize the
gerbils (54). Together, these data indicate that once lost,
the ability of in vitro-passaged H. pylori G1.1 to colonize
Mongolian gerbils cannot easily be regained in vitro or even by in vivo
passage through mice.
Effect of selected host factors on experimental infection of gerbils. In parallel with the gerbils normally purchased from Harlan Sprague-Dawley, 15 of 15 animals from Charles River Laboratories challenged with G1.1 were colonized with an average of 9.7 × 104 CFU per stomach for up to 20 weeks, and the results indicate that both the systemic immune response and gastric histopathology were the same as described for the Harlan animals, consistent with the common origin of gerbils available in the United States (see below).
To examine whether the sex of Mongolian gerbils affects experimental infection, female gerbils (from Harlan) were challenged with cagA-positive (G1.1, B128) or cagA-negative (B108) H. pylori strains that had been previously passaged through male gerbils. In ongoing experiments, 2 of 3, 5 of 6, and 3 of 3 female gerbils in each group were still infected at 1, 2, 4, 8, 12, and 16 weeks, respectively, after challenge with G1.1 (19 of 21); 3 of 3, 2 of 2, 2 of 2, and 2 of 2 were still infected after challenge with B108 (9 of 9); and 2 of 2 were still infected at each of 1, 2, 4, 6, 8, and 12 weeks after challenge with B128 (12 of 12). Together, these preliminary results indicate that neither the origin of the Mongolian gerbils purchased from different U.S. sources nor the sex of the animals markedly influences their susceptibility to the early stage of experimental infection with H. pylori.RUT.
Of 99 gerbils infected with G1.1WT, the RUT after 12 h was positive in 84 (85%), equivocally positive in 10 (10%), and
negative in 5 (5%) of the animals. The mean log10 CFU ± SEM/stomach determined by quantitative culture of samples from the
RUT-positive animals (4.60 ± 0.07) was higher than in the
equivocally RUT-positive animals (4.31 ± 0.14; not significant),
and the RUT-negative animals (3.85 ± 0.35; P = 0.013 by Student's t test, P = 0.021 by
one-way analysis of variance). Of the 25 gerbils infected with
G1.1V
, the number of infected animals with truly positive
RUT was smaller (15 animals [60%]; P = 0.012 by
Fisher's exact test) and the number with only equivocal RUT was larger
(8 animals [32%]; P = 0.009 by Fisher's exact test)
compared with those infected with G1.1WT, and the remaining 2 (8%)
animals both were RUT negative. In contrast to the infection with
G1.1WT, where the lack of RUT positivity was related to lighter
colonization of the animals, for the G1.1V
-infected
animals the mean log10 CFU/stomach of the RUT-positive (4.70 ± 0.07) and the RUT-equivocal animals (4.54 ± 0.24)
were similarly high. Of the 25 animals infected with
G1.1C
, 23 (92%) had a positive RUT and 2 (8%) had an
equivocally positive RUT. The gastric homogenates of a total of 40 control animals challenged with brucella broth alone, as well as those
of 131 animals that did not become infected after challenge with either the original or the in vitro-passaged strain G1.1WT, mutant
G1.1V
or G1.1U
, or various
cagA-negative wild-type strains, were consistently negative,
indicating the absence of urease-positive organisms in gastroduodenal
homogenates of uninfected gerbils.
was chiefly responsible for decreased sensitivity.
Since the RUT was evaluated only after 12 h, a correlation between
the CFU and the time elapsed until test positivity could not be made.
Histopathologic testing.
Having established colonization of
gerbils with several H. pylori wild-type and mutant strains,
we asked whether colonization induced gastroduodenal inflammation. To
exclude the possibility that gastric histopathologic changes were
induced by the inoculation procedure itself, a total of 40 (control)
animals challenged with brucella broth alone in different experiments
were examined for histopathologic changes (the number of animals is
given in parentheses) 0 (5 animals), 1 (2), 2 (7), 3 (3), 4 (5), 6 (6),
8 (5), 12 (1), 16 (2), 20 (1), 24 (1), or 32 (2) weeks after
inoculation. None of these animals, which covered the entire age range
of animals evaluated for histopathologic changes in this study,
developed gastric mucosal inflammation (Fig.
3A) or silver-stainable
spiral organisms at the mucosal surface and particularly in gastric
glandular lumina (Fig. 3B) 1 to 32 weeks after challenge. Two control
animals had chronic mucosal inflammation (grade 1) of the duodenum.
Similarly, the gastric histologic findings of 14 animals challenged
with G1.1U
and sacrificed after 1 to 12 weeks were
normal. In both infected and uninfected animals, a band of amorphous
material that was slightly silver stainable was visible on the mucosal
surface and could occasionally hamper the identification of
silver-stainable spiral organisms in this location. In contrast,
silver-stainable spiral organisms evaluated as H. pylori
were seen on the mucosal surface only when the underlying glands were
infected.
|
4 weeks
with G1.1 did not show antral inflammatory changes, indicating the
nearly universal induction of inflammation by experimental H. pylori infection. Antral lymphoid aggregates (Fig. 3H) occurred
after 6 weeks of infection and were observed in 30 (79%) of 38 animals
by 12 weeks. A few large lymphoid aggregates contained germinal centers
(Fig. 3I). Whereas the histologic scores for H. pylori on
the mucosal surface were unrelated to the mean CFU determined by
quantitative culture, gastric gland scores of 1, 2, and 3 were
associated with increasing log10 CFU in culture of
4.22 ± 0.24, 4.56 ± 0.11, and 4.65 ± 0.17, respectively; however, these differences were not significant because
of the large variability of the CFU. In contrast to the antrum, no
silver-stainable organisms or inflammatory changes were detectable in
the duodenum of gerbils infected with H. pylori G1.1 and
only two animals also had gastric body inflammation (after 8 and 32 weeks of infection, including the animal with a gastric ulcer).
|
or
G1.1V
mutant for up to 12 weeks after challenge (Fig.
5); long-term comparative studies will
show whether or not differences appear later. Also, preliminary results
indicate that gastritis induced by fresh human clinical
cagA-positive or cagA-negative H. pylori isolates is similar to that induced by strain G1.1WT or its
mutants (54).
|
Serum antibody response to H. pylori.
The serum antibody
response to H. pylori G1.1 was monitored from prechallenge
to 12 weeks post-challenge in 21 animals (Fig. 6). H. pylori infection was
documented by culture and histologic testing in all animals. As
detected by using goat anti-mouse IgG or IgM conjugates, both the serum
IgG and IgM antibody responses to H. pylori whole-cell
sonicate varied substantially among individual animals (Fig. 6A and B).
There was no correlation of the antibody responses with bacterial CFU
at 12 weeks or with the scores for chronic superficial or deep gastric
inflammation. Whereas IgG antibody levels steadily rose for up to 12 weeks after challenge, IgM antibody levels in most animals showed a
biphasic course with an early peak at 2 weeks and then a progressive
rise until 12 weeks. Compared with the prechallenge antibody levels,
levels from
2 weeks after challenge all were significantly
(P < 0.01) higher for both IgG and IgM (Fig. 6C). This
phenomenon allows confirmation of H. pylori infection after
2 weeks of challenge without the need to sacrifice the animals.
|
| |
DISCUSSION |
|---|
|
|
|---|
Our results confirm (29, 30, 41, 59, 60) that experimental infection of Mongolian gerbils with H. pylori is possible and indicate that stable colonization occurs for at least 32 weeks, which reproducibly induces gastric inflammation and a systemic immune response. For the first time, isogenic mutants were studied in this rodent model. The strains that can infect gerbils include several cagA-positive and cagA-negative human H. pylori isolates that now are available for in vivo studies; the availability of multiple strains is a prerequisite for the study of mixed infections.
Reproducible induction of gastritis in conventional mice thus far is restricted to selected and adapted H. pylori strains such as the Sydney strain (39), and several reports describe minimal or no inflammation with H. pylori strains that have not been preselected (29, 40, 42). Gastritis in animals infected for 4 weeks to 5 months with H. pylori G1.1 was significantly greater in gerbils than in several commonly used mouse strains (including C57BL/10, C57BL/6, BALB/c, C3H/HeJ, C3H/HeOuJ, and C3H/HeSnJ) (54). This finding suggests that gastritis induced in gerbils, at least in the short term, is more pronounced than in mice infected with strain G1.1. Induction of gastritis in gerbils infected with strains other than G1.1 (54) supports the view that gerbils are suitable and are potentially superior to mice for studying experimental H. pylori gastritis, provided that host genotypic characteristics are not the focus of interest. The longer life span of gerbils than of mice (9) and the larger amount of gastric tissue available for histologic examination may represent additional advantages.
Consistent with previous reports from Japan (29, 30, 41), the H. pylori viable counts per gerbil stomach were around 105 CFU, gastric inflammation affected mainly or exclusively the antrum, and inflammation increased with increasing time after H. pylori inoculation. Both in our study and in the cited reports, gastric histopathologic findings were confined to H. pylori-infected animals as detected by culture, histologic testing, and RUT. In contrast, in gerbils that were not challenged or were unsuccessfully challenged, neither H. pylori nor other urease-positive organisms could be cultured from the gastroduodenal mucosa, no spiral organisms were found in silver stains in histologic examinations, RUT results were consistently negative, and no serum antibodies to H. pylori whole-cell sonicates were detected. In attempts to recover H. pylori from small intestinal, cecal, or distal colonic contents of H. pylori-infected gerbils by using selective and nonselective media, we could detect neither H. pylori nor other urease-positive bacteria. Culture of gastric homogenates from infected gerbils on nonselective blood agar plates on average yielded fewer colonies that were morphologically consistent with H. pylori, compared with the yield for the selective medium normally used (54). Although cultures on nonselective media usually were more heavily contaminated, the diminished Helicobacter growth is evidence against the concomitant presence of Helicobacter species other than H. pylori. In gnotobiotic gerbils carrying a defined six-member murine microflora, the gastrointestinal flora did not differ from that of conventional gerbils, except for the presence of larger numbers of gastric Bacteroides spp. in the former (5). Because gerbils, like other rodents, are coprophagic, their lower intestinal microflora could be of importance for the gastric microflora. However, in a survey of anaerobic and aerobic bacteria in the lower intestinal tract of Mongolian gerbils, organisms consistent with Helicobacter species were not identified (57). Although these studies were not carried out with the specific aim of identifying Helicobacter species, these data and the low prevalence of naturally occurring gastritis in gerbils reported in the literature (6) indicate that even if natural colonization of gerbils with Helicobacter species other than H. pylori does occur, its relevance for induction of gastritis is limited. Clearly, with the future use of the gerbil model of H. pylori infection in mind, further characterization of the gastrointestinal microflora of gerbils with special emphasis on Helicobacter species should be performed (22).
In contrast to studies from Japan, the gerbils in our experiments were challenged three times to reproducibly achieve colonization, the prevalence of gastric ulcers seemed to be lower, and intestinal metaplasia was not a prominent finding. Whether these differences are related to genetic host differences (43) and/or bacterial factors will have to be addressed in future experiments, but they suggest the possibility of establishing different disease models by appropriate selection of the gerbils and/or the colonizing H. pylori strains (30). The undefined genetic background of our outbred gerbils is a disadvantage compared to the use of genetically defined inbred mouse strains, which are superior for examining the effect of differences in host genotype, provided that the animals can be reproducibly infected with H. pylori. Although three orogastric challenges represent a greater effort during the experimental procedures, this protocol is well tolerated by the animals, never limited the number of animals included in different types of experiments, and, more importantly, ensured that lack of colonization reflects the characteristics of the bacterial strain challenge rather than slight technical differences in the challenge procedure. Whereas Matsumoto et al. (41) reported that two of their four animals had gastric ulcers after 16 weeks of infection, the ulcer incidence in the report by Hirayama is not indicated and ulcers occurred after 6 months of infection or more. Therefore, comparison of the ulcer incidences is difficult on the basis of the available data. Induction of intestinal metaplasia during H. pylori infection does not seem to be a general phenomenon. In contrast to the one positive report by Hirayama et al. (30), occurrence of intestinal metaplasia was not evident in our animals, and it is not mentioned in the report of Matsumoto et al. (41), who used animals from the same source as that used by Hirayama et al. Because gastric goblet cells normally occur in our uninfected animals without gastritis (54), it would be important to know whether the earlier diagnosis of intestinal metaplasia (30) was based mainly on the occurrence of goblet cells or on other criteria.
In vitro passage of H. pylori strains progressively reduces their ability to colonize the gerbil stomach, and the phenotypes necessary for colonization, although undefined at present, are not easily restored. However, animals could successfully be colonized with several isogenic mutants of strain G1.1 despite the in vitro time necessary to construct these from their wild-type parental strain. In contrast, six of seven unselected fresh human H. pylori isolates colonized the gerbil stomach. These results indicate that gerbils represent a suitable rodent model for in vivo comparisons of fresh human H. pylori isolates. Urease is essential for establishment of H. pylori colonization in gerbils, similar to gnotobiotic piglets (16), primates (28), nude mice (51), and ferrets (3). The exact contribution of urease is unknown, but effects on local pH could be tested by attempting to establish infection in animals treated with H2-blockers or proton pump inhibitors that would elevate gastric pH (18).
The vacuolating cytotoxin (VacA) is not essential for colonization, confirming results obtained with gnotobiotic piglets (17), although the infection rate was slightly lower with the vacA mutant than with the wild-type strain. The results of the RUT suggest that the lower infection rate could be associated with decreased urease activity of the vacA mutant in vivo or with decreased levels of colonization. H. pylori VacA is heterogeneous (12), and some strains produce little protein in vitro. The role of VacA in vivo is unknown, and it is not certain that the induction of vacuoles in eukaryotic cells is relevant to its biological role in vivo. We do not know the levels of VacA expression in vivo in humans; vacuole production in vitro may be induced at doses many times those occurring in vivo, for example. Nevertheless, the presence of two copies of vacA homologs in the H. pylori genome (50) suggests that VacA has an important conserved function. The association between toxigenic H. pylori strains and ulcer disease in humans (7) and the animal data (obtained with piglets and gerbils) indicating that VacA is not necessary for short-term colonization and does not influence gastric inflammation in the first 3 months suggest to us that VacA may be involved in long-term rather than acute events. The degree to which results from experimental mouse challenge with sonicates from H. pylori wild-type or vacA mutant strains (23) are applicable to the induction of gastric histopathologic changes during natural infection is not known.
Colonization of gerbils with the isogenic cagA mutant indicates that cagA itself is not essential for colonization. Since many H. pylori strains do not possess cagA (11, 52) or the complete cag island (8), it clearly is not necessary for the establishment of colonization in humans. However, reduced colonization of gerbils with fresh wild-type cagA-negative compared with cagA-positive isolates suggests that cagA could be a marker for genes in the cag island or elsewhere that enhance colonization ability in gerbils. In vivo passage through gerbils appeared to increase the ability of cagA-negative H. pylori strains to colonize the gerbil stomach. Therefore, reduced colonization may be restricted to the interspecies (human-to-gerbil) transfer of cagA-negative H. pylori strains but may not be true for the intraspecies (gerbil-to-gerbil) transfer of these organisms. That inflammation during the first 3 months of infection induced by both the cagA- and vacA-ablated H. pylori mutants was similar to that from the wild-type strain also is consistent with the induction of gastritis in mice by H. felis, which does not express CagA or VacA (43). Our model provides the basis for studying the in vivo effect of ablation of essentially any H. pylori gene, provided that the gene product is not crucial for colonization.
Gerbils from different U.S. sources tolerate colonization with H. pylori well, with no change in their expected weight gain in
captivity. In total, only one animal infected with strain G1.1 (2% of
48 animals observed for
8 weeks) developed a gastric ulcer. Whereas
strain G1.1 was originally isolated from a patient with a duodenal
ulcer (31), no duodenal ulcers were observed in the gerbils.
This low rate of ulcerogenicity may be analogous to ulcerogenesis in
persistently colonized humans, in contrast to the findings in
gnotobiotic piglets (36). The histopathologic response to colonization also shows some notable similarities in the antrum between
humans and gerbils, with both acute polymorphonuclear leukocyte and
chronic lymphoplasmocytic cell infiltration. That not only were 99 of
101 gerbils challenged with strain G1.1 infected, but that also 97% of
the animals infected for
4 weeks had antral gastritis shows the
potential of this animal model. The interindividual variation in the
degree of inflammation may be related in part to the use of outbred
animals. Selection and mating of animals with strong responses could
lead to inbred gerbil strains with enhanced gastric inflammation during
H. pylori infection. The gradual increase of the chronic
deep inflammation during the first 24 weeks suggests that these deep
lesions may persist for the entire duration of H. pylori
infection, whereas the scores for chronic superficial inflammation
reach a plateau after about 12 weeks. The deep inflammation extending
beyond the muscularis mucosae is not observed in humans and may relate
to the presence of H. pylori in the lumina of the gastric
glands, in contrast to their usual absence in human gastric glands. The
histopathologic changes induced by several human clinical H. pylori isolates are virtually identical to those induced by strain
G1.1 (54).
The variability in antibody responses to H. pylori infection in gerbils parallels that observed in humans (45), and, similar to humans, chronic infection develops despite a host immune response. The present lack of gerbil-specific reagents represents a limitation of this rodent model of H. pylori infection; however, due to interspecies cross-reactions, mouse-specific antibodies can be used (25, 48, 53, 61) until gerbil-specific immune reagents are developed. The bacterial antigen preparation used for the ELISA to detect antibodies can be individualized based on the challenge H. pylori strain, with inclusion of many if not all of the relevant antigens to which immune responses may occur. Experimental infection with particular strains also excludes the possibility of mixed infection with several H. pylori strains differing in their antigenicity. The variability in antibody responses in gerbils may therefore reflect true heterogeneity of the host immune response to H. pylori antigens rather than lack of representativeness of the antigens used in the ELISA. Despite the marked variability in antibody responses between different hosts, and although isotype-specific detection of gerbil Igs by antibodies to mouse Ig isotypes may not be completely accurate, several clear trends emerge, as shown in Fig. 6C. The time course of the response is similar to that after experimental viral infection (34) or parenteral parasitic infection with Dipetalonema viteae or Leishmania major, where elevated antibody levels occur in serum after 1 week of infection (1, 58). The early peak in the IgM response is similar to that observed in a human volunteer who ingested H. pylori (44), although the secondary rise differs; long-term studies should indicate whether there is parallelism with phenomena in humans. That the early IgM peak immediately precedes the peak of the histologic score for H. pylori in gastric glands suggests the existence of at least a temporal relationship. The steady rise in IgG levels also parallels human responses; the decreasing numbers of bacteria observed in the gastric glands may reflect the development of an immune response that limits the bacterial population in this location. The increase in the IgG levels in serum and in the number of mononuclear cells in the lamina propria, after the numbers of neutrophils have reached a plateau, suggests that a mature immunological response to the organism is developing.
In conclusion, specific advantages of the gerbil model outweigh its present limitations and suggest applications that are complementary to those of existing rodent models. Limitations include the lack of information about host genetics, gastric physiology, and gastrointestinal microflora and the lack of gerbil-specific immune reagents. Experimental infection of Mongolian gerbils with H. pylori represents a versatile model, since it offers the technical advantage of a small laboratory animal with good susceptibility to experimental H. pylori infection, a brisk gastric inflammatory and systemic immune response, and prolonged colonization. For colonization, bacterial strain characteristics appeared more important than host characteristics.
| |
ACKNOWLEDGMENTS |
|---|
We thank S. Matsumoto (Fujisawa Pharmaceutical Company, Osaka, Japan) and M. Karita for making available mouse-passaged H. pylori CPY3401, M. Karita for providing helpful technical comments, and R. M. Peek and J. Höök-Nikanne for providing clinical H. pylori isolates.
This work was supported in part by the Pathology and Research Services of the Departments of Veterans Affairs and by grants DK 50837 and DK 53707 from the National Institutes of Health.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Vanderbilt University School of Medicine, A-3310 Medical Center North, Nashville, TN 37232-2605. Phone: (615) 322-2035. Fax: (615) 343-6160. E-mail: Martin.Blaser{at}mcmail.vanderbilt.edu.
Editor: V. A. Fischetti
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Abraham, D.,
D. J. Weiner, and J. P. Farrell.
1986.
Cellular and humoral immune responses of jirds resistant to Dipetalonema viteae infection.
Infect. Immun.
52:742-747 |
| 2. |
Akopyanz, N.,
N. O. Bukanov,
T. U. Westblom,
S. Kresovich, and D. E. Berg.
1992.
DNA diversity among clinical isolates of Helicobacter pylori detected by PCR-based RAPD fingerprinting.
Nucleic Acids Res.
20:5137-5142 |
| 3. | Andrutis, K. A., J. G. Fox, D. B. Schauer, R. P. Marini, J. C. Murphy, L. Yan, and J. V. Solnick. 1995. Inability of an isogenic urease-negative mutant strain of Helicobacter mustelae to colonize the ferret stomach. Infect. Immun. 63:3722-3725[Abstract]. |
| 4. | Andrutis, K. A., J. G. Fox, D. B. Schauer, R. P. Marini, X. Li, L. Yan, C. Josenhans, and S. Suerbaum. 1997. Infection of the ferret stomach by isogenic flagellar mutant strains of Helicobacter mustelae. Infect. Immun. 65:1962-1966[Abstract]. |
| 5. |
Bartizal, K. F.,
B. S. Wostmann, and M. Wagner.
1984.
Distribution and effects of a defined six-member murine-derived microflora in gnotobiotic gerbils.
Appl. Environ. Microbiol.
47:746-751 |
| 6. | Bingel, S. A. 1995. Pathologic findings in an aging Mongolian gerbil (Meriones unguiculatus) colony. Lab. Anim. Sci. 45:597-600[Medline]. |
| 7. | Blaser, M. J. 1996. Role of vacA and the cagA locus of Helicobacter pylori in human disease. Aliment. Pharmacol. Ther. 10(Suppl. 1):73-77. |
| 8. |
Censini, S.,
C. Lange,
Z. Xiang,
J. E. Crabtree,
P. Ghiara,
M. Borodovsky,
R. Rappuoli, and A. Covacci.
1996.
cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors.
Proc. Natl. Acad. Sci. USA
93:14648-14653 |
| 9. | Cheal, M. L. 1986. The gerbil: a unique model for research on aging. Exp. Aging Res. 12:3-21[Medline]. |
| 10. | Chen, X. G., P. Correa, J. Offerhaus, E. Rodriguez, F. Janney, E. Hoffmann, J. Fox, F. Hunter, and S. Diavolitsis. 1986. Ultrastructure of the gastric mucosa harboring Campylobacter-like organisms. Am. J. Clin. Pathol. 86:575-582[Medline]. |
| 11. |
Covacci, A.,
S. Censini,
M. Bugnoli,
R. Petracca,
D. Burroni,
G. Macchia,
A. Massone,
E. Papini,
Z. Xiang,
N. Figura, and R. Rappuoli.
1993.
Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer.
Proc. Natl. Acad. Sci. USA
90:5791-5795 |
| 12. |
Cover, T. L.,
M. K. R. Tummuru,
P. Cao,
S. A. Thompson, and M. J. Blaser.
1994.
Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains.
J. Biol. Chem.
269:10566-10573 |
| 13. | Cover, T. L., and M. J. Blaser. 1996. Helicobacter pylori, a paradigm for chronic mucosal inflammation: pathogenesis and implications for eradication and prevention. Adv. Intern. Med. 41:85-117[Medline]. |
| 14. | Dubois, A., N. Fiala, L. M. Heman-Ackah, E. S. Drazek, A. Tarnawski, W. N. Fishbein, G. I. Perez-Perez, and M. J. Blaser. 1994. Natural gastric infection with Helicobacter pylori in monkeys: a model for spiral bacteria infection in humans. Gastroenterology 106:1405-1417[Medline]. |
| 15. | Dubois, A., D. E. Berg, E. T. Incecik, N. Fiala, L. M. Heman-Ackah, G. I. Perez-Perez, and M. J. Blaser. 1996. Transient and persistent experimental infection of nonhuman primates with Helicobacter pylori: implications for human disease. Infect. Immun. 64:2885-2891[Abstract]. |
| 16. |
Eaton, K. A.,
C. L. Brooks,
D. R. Morgan, and S. Krakowka.
1991.
Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets.
Infect. Immun.
59:2470-2475 |
| 17. | Eaton, K. A., T. L. Cover, M. K. R. Tummuru, M. J. Blaser, and S. Krakowka. 1997. Role of vacuolating cytotoxin in gastritis due to Helicobacter pylori in gnotobiotic piglets. Infect. Immun. 65:3462-3464[Abstract]. |
| 18. |
Eaton, K. A., and S. Krakowka.
1994.
Effect of gastric pH on urease-dependent colonization of gnotobiotic piglets by Helicobacter pylori.
Infect. Immun.
62:3604-3607 |
| 19. | Engstrand, L. 1995. Potential animal models of Helicobacter pylori infection in immunological and vaccine research. FEMS Immunol. Med. Microbiol. 10:265-270[Medline]. |
| 20. | Fox, J. G., P. Correa, N. S. Taylor, A. Lee, G. Otto, J. C. Murphy, and R. Rose. 1990. Helicobacter mustelae-associated gastritis in ferrets. An animal model of Helicobacter pylori gastritis in humans. Gastroenterology 99:352-361[Medline]. |
| 21. | Fox, J. G., M. Batchelder, R. Marini, L. Yan, L. Handt, X. Li, B. Shames, A. Hayward, J. Campbell, and J. C. Murphy. 1995. Helicobacter pylori-induced gastritis in the domestic cat. Infect. Immun. 63:2674-2681[Abstract]. |
| 22. | Fox, J. G., and A. Lee. 1997. The role of Helicobacter species in newly recognized gastrointestinal tract diseases of animals. Lab. Anim. Sci. 47:222-255[Medline]. |
| 23. | Ghiara, P., M. Marchetti, M. J. Blaser, M. K. R. Tummuru, T. L. Cover, E. D. Segal, L. S. Tompkins, and R. Rappuoli. 1995. Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA, and urease in a mouse model of disease. Infect. Immun. 63:4154-4160[Abstract]. |
| 24. |
Ghoshal, N. G., and H. S. Bal.
1989.
Comparative morphology of the stomach of some laboratory mammals.
Lab. Anim.
23:21-29 |
| 25. |
Gorenflot, A.,
E. Precigout,
G. Bissuel,
O. Lecointre,
P. Brasseur,
E. Vidor,
M. L'Hostis, and J. Schrevel.
1990.
Identification of major Babesia divergens polypeptides that induce protection against homologous challenge in gerbils.
Infect. Immun.
58:4076-4082 |
| 26. | Harlan Sprague-Dawley, Inc. 1997. Personal communication. |
| 27. | Hazell, S. L., T. J. Borody, A. Gal, and A. Lee. 1987. Campylobacter pyloridis gastritis I: detection of urease as a marker of bacterial colonization and gastritis. Am. J. Gastroenterol. 82:292-296[Medline]. |
| 28. | Hirata, I., T. Itoh, K. Suzuki, Y. Irikura, S. Kaneko, S. Takahashi. 1993. Colonization of urease positive and negative strains of Helicobacter pylori in gastric mucosa of cynomolgus monkeys. Acta Gastroenterol. Belg. 56(Suppl.):112. |
| 29. | Hirayama, F., S. Takagi, Y. Yokoyama, E. Iwao, and Y. Ikeda. 1996. Establishment of gastric Helicobacter pylori infection in Mongolian gerbils. J. Gastroenterol. 31(Suppl. IX):24-28. |
| 30. | Hirayama, F., S. Takagi, H. Kusuhara, E. Iwao, Y. Yokoyama, and Y. Ikeda. 1996. Induction of gastric ulcer and intestinal metaplasia in Mongolian gerbils infected with Helicobacter pylori. J. Gastroenterol. 31:755-757[Medline]. |
| 31. | Karita, M., T. Kouchiyama, K. Okita, and T. Nakazawa. 1991. New small animal model for human gastric Helicobacter pylori infection: success in both nude and euthymic mice. Am. J. Gastroenterol. 86:1596-1603[Medline]. |
| 32. | Karita, M., Q. Li, D. Cantero, and K. Okita. 1994. Establishment of a small animal model for human Helicobacter pylori infection using germ-free mouse. Am. J. Gastroenterol. 89:208-213[Medline]. |
| 33. | Karita, M., M. K. R. Tummuru, H. P. Wirth, and M. J. Blaser. 1996. Effect of growth phase and acid shock on Helicobacter pylori cagA expression. Infect. Immun. 64:4598-4605[Abstract]. |
| 34. | Kariwa, H., J. Arikawa, I. Takashima, and N. Hashimoto. 1992. Development and application of protein G antibody assay for the detection of antibody to hantavirus. J. Virol. Methods 37:345-354[Medline]. |
| 35. |
Krakowka, S.,
D. R. Morgan,
W. G. Kraft, and R. D. Leunk.
1987.
Establishment of gastric Campylobacter pylori infection in the neonatal gnotobiotic piglet.
Infect. Immun.
55:2789-2796 |
| 36. | Krakowka, S., K. A. Eaton, and D. M. Rings. 1995. Occurrence of gastric ulcers in gnotobiotic piglets colonized by Helicobacter pylori. Infect. Immun. 63:2352-2355[Abstract]. |
| 37. |
Lambert, J. R.,
M. Borromeo,
K. J. Pinkard,
H. Turner,
C. B. Chapman, and M. L. Smith.
1987.
Colonization of gnotobiotic piglets with Campylobacter pyloridis an animal model?
J. Infect. Dis.
155:1344-1348[Medline].
|
| 38. | Lee, A., J. G. Fox, G. Otto, and J. C. Murphy. 1990. A small animal model of human Helicobacter pylori active chronic gastritis. Gastroenterology 99:1315-1323[Medline]. |
| 39. | Lee, A., J. O'Rourke, M. Corazon de Ungria, B. Robertson, G. Daskalopoulos, and M. F. Dixon. 1997. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 112:1386-1397[Medline]. |
| 40. | Marchetti, M., B. Aricò, D. Burroni, N. Figura, R. Rappuoli, and P. Ghiara. 1995. Development of a mouse model of Helicobacter pylori infection that mimics hum |